TD Cowen analyst Nicholas Lorusso raised the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $10.00 (from $7.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE